| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | 56,060 | 86,451 | -30,917 | -58,884 |
| Stock-based compensation expense | 1,889 | 1,733 | 1,941 | 4,518 |
| Loss on early extinguishment of 2026 notes | NaN | NaN | 0 | -2,968 |
| (gain) loss on early extinguishment of debt-Convertible Senior Notes2026 | NaN | -2,968 | NaN | NaN |
| Amortization of discount and issuance costs-Convertible Debt | 1,460 | 1,479 | 1,478 | 988 |
| Amortization of discount and issuance costs on debt-Initial Term Loan | NaN | -5,578 | NaN | NaN |
| Gain on sale of zaltenibart | NaN | 237,594 | NaN | NaN |
| Depreciation and amortization | 239 | 235 | 240 | 489 |
| (gain) loss on early extinguishment of debt-Initial Term Loan | NaN | 20,579 | NaN | NaN |
| Remeasurement on fair value of financial instruments | 73,146 | -136,037 | -8,822 | 8,142 |
| Non-cash interest remeasurement on omidria royalty obligation | -1,410 | -33,435 | NaN | NaN |
| Non-cash interest on omidria contract royalty asset | 3,132 | 3,196 | 3,682 | 7,839 |
| Remeasurement on omidria contract royalty asset | NaN | -3,726 | 13,402 | 2,981 |
| Remeasurement of omidria contract royalty asset | 32,552 | NaN | -22,293 | -11,878 |
| Amortization of discount and issuance costs-Loans Payable | 4,727 | NaN | -1,513 | -3,214 |
| Accretion on u.s. government treasury bills, net | NaN | 0 | 0 | 0 |
| Omidria contract royalty asset | -7,343 | -9,219 | -9,153 | -15,251 |
| Prepaid expenses and other | -87 | 4,024 | -2,398 | -315 |
| Receivables | 1,115 | 4,009 | 632 | -1,463 |
| Inventory | 183 | NaN | NaN | NaN |
| Accounts payable and accrued expense | -979 | -1,753 | 3,130 | 3,205 |
| Net cash used in operating activities | -14,506 | -39,842 | -18,473 | -57,779 |
| Gross cash proceeds from sale of zaltenibart | NaN | 240,000 | NaN | NaN |
| Proceeds from the sale and maturities of investments | 30,050 | 38,400 | 10,500 | 61,000 |
| Purchases of investments | 1,316 | 166,854 | 17,350 | 1,108 |
| Purchases of property and equipment | 0 | 0 | 11 | 54 |
| Net cash provided by investing activities | 28,734 | 111,546 | -6,861 | 59,838 |
| Proceeds from registered offering, net-Securities Purchase Agreement With Polar Asset Management | NaN | 0 | 20,327 | NaN |
| Proceeds from registered offering, net-At The Market Equity Offering Program | NaN | 3,724 | 15,292 | NaN |
| Exercise of stock options | 7,895 | NaN | 225 | 88 |
| Proceeds from sale of future royalties | NaN | 0 | 0 | 0 |
| Proceeds upon exercise of stock options | NaN | 7,651 | NaN | NaN |
| Proceeds from issuance of common stock from the atm facility, net | NaN | NaN | NaN | 6,287 |
| Payment on maturity of 2023 notes | NaN | 0 | NaN | NaN |
| Repayment of 2026 notes | 17,077 | 67,077 | NaN | NaN |
| Cash paid to repurchase 2026 notes | NaN | 0 | 0 | 0 |
| Principal payments on omidria royalty obligation | 4,670 | 4,700 | 3,555 | 6,701 |
| Payment of debt issuance costs related to 2029 notes | NaN | NaN | 0 | 2,837 |
| Prepayment premium and transaction costs on repayment of term debt-Initial Term Loan | NaN | 3,544 | NaN | NaN |
| Repurchases of common stock | 4,152 | 0 | 0 | 0 |
| Payment of debt issuance costs related to 2029 notes-The2029Notes | NaN | 2,837 | NaN | NaN |
| Net share settlement of equity awards | 4,108 | NaN | NaN | NaN |
| Payments on finance lease obligations | 183 | 180 | 177 | 392 |
| Net cash used in financing activities | -21,982 | -64,439 | 25,825 | -3,555 |
| Net increase (decrease) in cash and cash equivalents | -7,754 | 7,265 | 491 | -1,496 |
| Cash and cash equivalents at beginning of period | 9,660 | 2,395 | 3,400 | NaN |
| Cash and cash equivalents at end of period | 1,906 | 9,660 | 2,395 | NaN |
OMEROS CORP (OMER)
OMEROS CORP (OMER)